In consultation: Guidance and quality standards
Showing 1 to 4 of 4
Title | Consultation | Type | Consultation end date |
---|---|---|---|
Elacestrant for treating oestrogen receptor-positive, HER2-negative advanced breast cancer with an ESR1 mutation after at least 1 endocrine treatment [ID6225] | Draft guidance | Technology appraisal guidance | |
Intrapartum care - uterotonics for postpartum haemorrhage | Draft guidance consultation | NICE guideline | |
Cabotegravir for preventing HIV-1 in adults and young people [ID6255] | Draft guidance | Technology appraisal guidance | |
Intravascular lithotripsy for calcified coronary arteries during percutaneous coronary intervention | Interventional procedure consultation | Interventional procedures guidance |